 | ||||
Insert Headline
Insert text here.
SHIKARI® Q-VEDO
Enzyme immunoassay for the quantitative determination of Vedolizumab (Entyvio®) in serum and plasma. The Matriks Biotek Shikari Q-VEDO ELISA has been especially developed for the quantitative analysis of Vedolizumab in serum and plasma samples.
SHIKARI® S-ATV
10ul
140 min
Serum, plasma
96
30 ng/mL
85-115%
1 year
The Matriks Biotek Antibody to Vedolizumab(Entyvio®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Vedolizumab(Entyvio®) in serum and plasma. It is for professional use only.
Calibration Curve
SHIKARI® Q-VEDO & S-ATV
Vedolizumab (Entyvio®)
Enzyme immunoassay for the quantitative determination of Vedolizumab(Entyvio®) in human serum and plasma
Enzyme immunoassay for the qualitative determination of specific antibodies to Vedolizumab(Entyvio®) in human serum and plasma
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
UST-FD-STE: $1,000.00 Lead time: 1-2 weeks
UST-QLS-STE: $1,000.00 Lead time: 1-2 weeks
.....................................................
.....................................................
Iwai North America Inc.
541 Taylor Way Suite# 4
San Carlos, CA 94070
Phone : (650) 486-1541
Fax : (650) 394-8638
Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
